Home » Reports » Broker Ratings » AstraZeneca plc 14.4% Potential Upside Indicated by Jefferies International
broker ratings

AstraZeneca plc 14.4% Potential Upside Indicated by Jefferies International

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Jefferies International. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 5950 GBX on its stock. This would imply the analyst believes there is now a potential upside of 14.4% from today’s opening price of 5201 GBX. Over the last 30 and 90 trading days the company share price has increased 236.5 points and increased 401 points respectively. The 1 year high for the share price is 5520 GBX while the 52 week low is 4260 GBX.

AstraZeneca plc has a 50 day moving average of 5,042.41 GBX and the 200 Day Moving Average price is recorded at 4,959.33. There are currently 1,263,812,348 shares in issue with the average daily volume traded being 2,091,112. Market capitalisation for LON:AZN is £66,122,662,047 GBP.